341 related articles for article (PubMed ID: 15249440)
1. Delayed post-myocardial infarction invasive measures, helpful or harmful? A subgroup analysis.
Yip HK; Wu CJ; Yang CH; Chang HW; Chen SM; Hung WC; Hang CL
Chest; 2004 Jul; 126(1):38-46. PubMed ID: 15249440
[TBL] [Abstract][Full Text] [Related]
2. Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.
Brener SJ; Moliterno DJ; Aylward PE; van't Hof AW; Ruźyllo W; O'Neill WW; Hamm CW; Westerhout CM; Granger CB; Armstrong PW;
Eur Heart J; 2008 May; 29(9):1127-35. PubMed ID: 18375399
[TBL] [Abstract][Full Text] [Related]
3. Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
Yip HK; Wu CJ; Chang HW; Hsieh YK; Fang CY; Chen SM; Chen MC
Chest; 2003 Sep; 124(3):962-8. PubMed ID: 12970024
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of circulating levels of endothelin-1 in patients after acute myocardial infarction undergoing primary coronary angioplasty.
Yip HK; Wu CJ; Chang HW; Yang CH; Yu TH; Chen YH; Hang CL
Chest; 2005 May; 127(5):1491-7. PubMed ID: 15888819
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
[TBL] [Abstract][Full Text] [Related]
7. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.
Yip HK; Chen MC; Chang HW; Hang CL; Hsieh YK; Fang CY; Wu CJ
Chest; 2002 Oct; 122(4):1322-32. PubMed ID: 12377860
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of ischemic mitral regurgitation during the acute phase of ST elevation myocardial infarction treated with primary coronary intervention for left ventricular remodeling in long-term follow-up.
Wita K; Berger-Kucza A; Filipecki A; Turski M; Bochenek T; Wróbel W; Lelek M; Weglarz P; Elzbieciak M; Trusz-Gluza M
Coron Artery Dis; 2010 Sep; 21(6):325-9. PubMed ID: 20453641
[TBL] [Abstract][Full Text] [Related]
9. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention.
Cheng CI; Yeh KH; Chang HW; Yu TH; Chen YH; Chai HT; Yip HK
Chest; 2004 Jul; 126(1):47-53. PubMed ID: 15249441
[TBL] [Abstract][Full Text] [Related]
10. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
Ke D; Zhong W; Fan L; Chen L
Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
[TBL] [Abstract][Full Text] [Related]
11. Effects and safety of intracoronary thrombectomy using transradial application of the PercuSurge distal balloon protection system in patients with early or recent myocardial infarction.
Chen YH; Wu CJ; Chang HW; Fang CY; Chen CJ; Yu TH; Chen SM; Hung WC; Cheng CI; Yip HK
Cardiology; 2004; 102(4):206-14. PubMed ID: 15452393
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcome of coronary artery aneurysm in patients with acute myocardial infarction undergoing a primary percutaneous coronary intervention.
Yip HK; Chen MC; Wu CJ; Hang CL; Hsieh KY; Fang CY; Yeh KH; Fu M
Cardiology; 2002; 98(3):132-40. PubMed ID: 12417812
[TBL] [Abstract][Full Text] [Related]
13. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
[TBL] [Abstract][Full Text] [Related]
14. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
Hassan AK; Liem SS; van der Kley F; Bergheanu SC; Wolterbeek R; Bosch J; Bootsma M; Zeppenfeld K; van der Laarse A; Atsma DE; Jukema JW; Schalij MJ
Catheter Cardiovasc Interv; 2009 Aug; 74(2):335-43. PubMed ID: 19642182
[TBL] [Abstract][Full Text] [Related]
15. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease.
Han YL; Wang B; Wang XZ; Li Y; Wang SL; Jing QM; Wang G; Ma YY; Luan B
Chin Med J (Engl); 2008 Dec; 121(23):2384-7. PubMed ID: 19102953
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
[TBL] [Abstract][Full Text] [Related]
18. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
[TBL] [Abstract][Full Text] [Related]
19. Patency of infarct related artery after pharmacological reperfusion during transfer to primary percutaneous coronary intervention influences left ventricular function and one-year clinical outcome.
Dudek D; Rakowski T; El Massri N; Sorysz D; Zalewski J; Legutko J; Dziewierz A; Rzeszutko L; Zmudka K; Piwowarska W; De Luca G; Kaluza GL; Janion M; Dubiel JS
Int J Cardiol; 2008 Mar; 124(3):326-31. PubMed ID: 17433468
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.
Mehta RH; Ou FS; Peterson ED; Shaw RE; Hillegass WB; Rumsfeld JS; Roe MT;
JACC Cardiovasc Interv; 2009 Jan; 2(1):56-64. PubMed ID: 19463399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
